Immunosenescence is the age-related decline and remodeling of the immune system, profoundly influencing susceptibility to ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and ProTgen, a biotechnology company ...
MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today ...
Scientists have long known that the immune system plays a key role in aging. As people age, they have weaker responses to ...
Objective B-cell activating factor (BAFF) is essential for B-cell survival and innate immune activation, and its ...
NKT therapy, agenT-797, delivers context-dependent immune reprogramming showing activation in cancer and anti-inflammatory benefit in ARDS — ...
Scientists have long known that the immune system plays a key role in aging. As people age, they have weaker responses to ...
Merck highlights new long-term data and advancements across broad oncology portfolio and pipeline research at ASCO 2026: Rahway, New Jersey Wednesday, May 13, 2026, 11:00 Hrs [IST ...
Oligonucleotide-based therapeutics represent a frontier in immunology, regenerative medicine, and oncology, offering unparalleled precision in modulating ...
University of South Florida researchers developed a framework to test AI models that predict immune responses to antigens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results